We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...
Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing ...
Hikma's generics business, grew 9 per cent to $1.026 billion, surpassing the $1 billion revenue mark for the first time.
IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase ...
(HealthDay News) — Maternal health in pregnancy is associated with offspring autism, and these associations are largely attributed to familial confounding, according to a study published online Jan.
The Group reported revenue growth of 9% (9% in constant currency) to $3.127 billion compared to $2.875 billion in 2023) ...
Robust financial performance driven by full year 2024 royalty revenue growth of 28%Reiterating 2025 financial guidance of $180-$200 million in ...
Company Announcement Nanoform Finland Plc February 27, 2025 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform 2024 report: Deal discussions around product kernels intensify After a strong ...
Q4 2024 Results Conference Call February 26, 2025 11:00 AM ETCompany ParticipantsPeter Vozzo - ICR Healthcare, IRStacy Lindborg ...
The Institute is delighted to welcome four new Non-Executive Directors to the Board of Babraham Institute Enterprise (BIE) ...
The AVPN Southeast Asia Summit 2025, held at Fairmont Singapore on 24 and 25 February, brought together over 450 investors, ...